United States · FDA National Drug Code directory

divalproex sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2783_ab939570-1437-4742-952e-a93d011d0c05
Product NDC
71335-2783
Form
TABLET, DELAYED RELEASE
Composition / generic term
divalproex sodium
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20240626
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2783-1) · 71335-2783-1
  • 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2783-2) · 71335-2783-2
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2783-3) · 71335-2783-3
  • 120 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2783-4) · 71335-2783-4
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2783-5) · 71335-2783-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →